Trial Profile
A single ascending dose study to investigate the tolerability and pharmacokinetics of NSD-788 in healthy volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Apr 2008
Price :
$35
*
At a glance
- Drugs AN 788 (Primary)
- Indications Anxiety disorders; Depressive disorders
- Focus Adverse reactions
- Sponsors NeuroSearch
- 04 Apr 2008 New trial record.